Cardiovascualr Flashcards
what are the complications of AF and why
stroke and thromboembolism
due to AF causing stasis of the blood which can form a thrombi
what are the symptoms of AF
heart palpitations, SOB, chest pain, tiredness….
what are the three different types of AF
paroxysmal: symptoms stop within 48 hours of starting treatment
persistent: symptoms lasting longer than 7 days
permanent: constant symptoms
1st line treatment for AF
preferred 1st line rate control (beta blockers except sotalol)
OR
rate limiting CCB: verapamil and diltiazem
1st used as monotherapy them 2nd line use as combination
digoxin is used for sedentary patients, with HF, non-paroxysmal AF, in combo with Beta blocker if LVEF <40%
2nd line treatment for AF
rhythm control - cardioversion
pharmacological cardioversion: flecainide OR amiodarone
electrical cardioversion: DC cardioversion - preferred
must be anticoagulated 3 weeks prior and 4 weeks after
post cardioversion treatment
1st line: beta blocker
2nd line: sotalol, propafenone, amiodarone, flecainide (SPAF)
CI of propafenone and dronedarone
propafenone: IHD, LVF, HF
dronedarone: HF
management of paroxysmal AF
1st line: beta blocker
2nd line: sotalol, propafenone, amiodarone or flecainide
pill in pocket for PRN: flecainide or propafenone
assess stroke risk
management of atrial flutter
1st line: rate control - beta blocker or rate limiting CCB
2nd line: rhythm control (3 options)
- DC cardioversion
- pharmacological cardioversion: SPAF
- catheter ablation
flutters longer than 48 hours require 3 week anticoagulation prior and 4 weeks post
management of paroxysmal supraventricular tachycardia
usually terminates spontaneously
1st line: reflex vagal stimulation: valsalva maneuver, submerge face in ice water, sinus carotid massage (all whilst connected to ECG)
2nd line: IV adenosine
3rd line: IV verapamil
maintenance/ prophylaxis: beta blocker OR rate limiting CCB
management of ventricular tachycardia (stable and unstable)
pulseless ventricular tachycardia OR ventricular fibrillation = RESUS
unstable sustained ventricular tachycardia
- 1st line: DC cardioversion
- 2nd line: IV amiodarone
- 3rd line: repeat DC cardioversion
stable ventricular tachycardia
- 1st line: IV amiodarone
- 2nd line: DC cardioversion
non-sustained stable ventricular tachycardia:
- beta blockers
high risk patients = risk of cardiac arrest so must be maintained on:
- implant cardiovertable defibrillator
- can add beta blocker OR beta blocker plus amiodarone
management of high risk patients with ventricular tachycardia
risk of cardiac arrest so must be managed with:
implantable cardioverter defibrillator
may add beta blocker OR beta blocker PLUS amiodarone
management of torsades des pointes (prolonged QT interval)
IV magnesium sulphate beta blocker (Except sotalol) and atrial/ ventricular pacing can be considered
antiarrhythmic drugs should be avoided as they cause bradycardia which may prolong QT interval
causes of QT prolongation (torsades des pointes)
macrolides, quinolones, drugs that cause hypokalemia, TCAs, SSRIs, amiodarone, sotalol, haloperidol, antifungals
what are the antiarrhythmic drugs and the classes
class I: membrane stabilising - flecainide and lidocaine class II: beta blockers class III: sotalol and amiodarone class IV: rate limiting CCB's - diltiazem and verapamil
what is the loading regimen for amiodarone
200MG TDS 1 week then
200MG BD for 1 week then
200MG OD maintenance
what are the side effects and monitoring parameters for amiodarone
side effects:
corneal microdeposits: may cause blurred vision, stop if vision impairment
thyroid dysfunction: hypo or hyperthyroid due to iodine content
pulmonary toxicity: report on new/ progressive SOB, coughing
hepatotoxicity: stop on signs of liver impairment
photosensitivity: avoid sunlight and put on suncream for months after
monitoring: TFTs: before treatment and 6 months LFTs: before treatment and 6 months chest x ray: before treatment ECG and transaminase if using IV amiodarone annual eye examination
interactions of amiodarone
drugs that cause hypokalaemia: diuretics, gentamicin, theophylline, corticosteroids…
drugs that prolong QT interval: macrolides, quinolones, SSRI, TCAs, haloperidol…
CYP450 substrates: warfarin, COC, statins
CYP450 inducers: decrease concentration
CYP450 inhibitors: increase concentration
drugs that cause bradycardia: beta blockers and rate limiting CCB
digoxin: use with amiodarone - need to half digoxin dose
Patients who stopped amiodarone within last few months need to have close monitoring with the following drugs due to risk of heart block
- Sofosovir, daclatasivir, simeprevir, ledipasvir
therapeutic and toxicity range for digoxin
and when are levels taken and what is monitored
therapeutic: 0.7-2ng/ml
toxicity: 1.5-3ng/ml
taken 6-12 hours after dose
electrolytes and renal function
signs of digoxin toxicity and how to reverse this
bradycardia
Nausea and vomiting
confusion, dizziness
blurred/ yellow vision
reversal: digoxin specific antibody
interactions of digoxin
beta blockers: increase risk of AV block and increase plasma concentrations
Antidepressants: can cause arrythmia
drugs that cause hypokalaemia: increase risk of toxicity
CYP450 inducers: decreases concentration
CYP450 inhibitors: increases concentration
what are the indications for tranexamic acid and desmopressin in helping with clotting (reduce bleeding)
tranexamic acid: menorrhagia, surgeries and dental extraction
desmopressin: mild to moderate haemophilia and von willebrands disease
symptoms of VTE and PE
VTE: swelling, painful to touch, hot leg (usually one calf)
PE: SOB, coughing, chest pain
2 types of prophylaxis for thromboembolism
mechanical: compression stockings
pharmacological: anticoagulants
- usually started within 14 hours of hospital admission
- assess risk of bleeding
- use if risk of VTE outweighs risk of bleed